Skip to content

Sonography-guided Resection of Brain Mass Lesions

Sonography-guided Resection of Brain Mass Lesions: a Prospective, Single Arm Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05484245
Acronym
SOMALI
Enrollment
100
Registered
2022-08-02
Start date
2022-09-01
Completion date
2027-08-31
Last updated
2026-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor, Brain, Meningioma of Brain, Glioma, Metastasis Brain

Keywords

intraoperative sonography, intraoperative ultrasound, brain tumor, meningioma, glioma, cerebral metastasis

Brief summary

The study aims to perform a comparative analysis of preoperative CT/MRI and intraoperative ultrasound findings in patients with hemispheric brain tumors (meningiomas, gliomas, metastases), and to develop an intraoperative ultrasound scanning algorithm for the differential diagnosis of residual tumor tissue and sonographic artifacts within the resection cavity.

Detailed description

Intraoperative sonography is widely utilized in neuro-oncology to localize brain tumors and evaluate the extent of resection. Ultrasound remains the only imaging modality that allows for real-time visualization of brain tissue. Furthermore, it is cost-effective and integrates seamlessly into the surgical workflow without cause for disruption. The primary limitations of sonography include a steep learning curve and lower spatial resolution compared to magnetic resonance imaging (MRI). While the integration of novel acoustic coupling fluids, contrast-enhanced ultrasound and elastography has expanded its efficacy, the localization of isoechoic lesions with poorly defined margins and the elimination of resection cavity artifacts remain significant challenges. The study aims to perform a comparative analysis of preoperative MRI/CT and intraoperative ultrasound findings in patients with hemispheric brain tumors (meningiomas, gliomas, metastases), and to develop an intraoperative ultrasound scanning algorithm for the differential diagnosis of residual tumor tissue and sonographic artifacts within the resection cavity. Intraoperatively the investigator will localize tumor, correlate its sonographic characteristics with preoperative MRI/CT data, and assess the extent of resection using intraoperative ultrasound across three distinct transducer positioning modes (superficial and deep transcavity, transcortical, and via transencephalotomy approaches).

Interventions

Surgeon detects brain mass lesion and assesses extent of it's resection with sonography

Sponsors

Sklifosovsky Institute of Emergency Care
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* meningioma * glioma * cerebral metastasis of solid tumors of any primary origin * supratentorial localization * age 18-80 years * intraoperative use of sonography.

Exclusion criteria

* history of brain tumor radiotherapy (except for a single-session stereotactic radiosurgery performed no earlier than 7 days prior to surgery) * anatomical features of the surgical approach that preclude correct positioning of the ultrasound transducer within the operative wound.

Design outcomes

Primary

MeasureTime frameDescription
Concordance rate between intraoperative sonographic tumor features and preoperative neuroimagingIntraoperativelyAssessment of target lesion visibility, size, echogenicity, homogeneity, and border demarcation in intraoperative sonography, and their direct comparison to preoperative magnetic resonance imaging or computed tomography baseline data
Sonographic differentiation accuracy of residual tumor and resection cavity artifactsIntraoperativelyEvaluation of intraoperative ultrasound accuracy in assessing the extent of resection by identifying the peripheral hyperechoic ring and differentiating true residual tumor tissue from sonographic artifacts within the resection cavity across three probe positioning modes.

Secondary

MeasureTime frameDescription
Sensitivity of intraoperative sonography to detect mass lesion compared to preoperative magnetic resonance imaging or computed tomography (in percents)IntraoperativelySensitivity = true detection of mass lesion / (true detection of mass lesion + inability to detect mass lesion) x 100
Sensitivity of intraoperative sonography to detect residual mass lesion compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgerySensitivity = true detection of residual mass lesion / (true detection of residual mass lesion + inability to detect residual mass lesion) x 100
Specificity of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgerySpecificity = true absence of residual mass lesion / (true absence of residual mass lesion + false detection of residual mass lesion) x 100
Positive predictive value of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgeryPositive predictive value = true detection of residual mass lesion / (true detection of residual mass lesion + false detection of residual mass lesion) x 100
Negative predictive value of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgeryNegative predictive value = true absence of residual mass lesion / (true absence of residual mass lesion + inability to detect residual mass lesion) x 100
Accuracy of intraoperative sonography to detect residual mass lesions compared to postoperative magnetic resonance imaging or computed tomography (in percents)Within 48 hours after surgeryAccuracy = (true detection of residual mass lesion + true absence of residual mass lesion) / (true detection of residual mass lesion + true absence of residual mass lesion + false detection of residual mass lesion + inability to detect residual mass lesion) x 100
Duration of mass lesion removal (in minutes)IntraoperativelyHow long did in take to remove mass lesion from starting of it's dissection till final evacuation
Extent of resection (in percents)Within 48 hours after surgeryExtent of resection = (preoperative tumor volume - postoperative tumor volume) / preoperative tumor volume x 100
Karnofsky performance status (in percents)Within 10 days after surgeryAssessment of patients' possibilities to self-service in Karnofsky Performance Status scale
Cerebral complicationsFrom admission to intensive care unit after surgery till hospital discharge, up to 365 daysWhich cerebral complications arose after surgery

Countries

Russia

Contacts

CONTACTAlexander Dmitriev, MD
dmitriev@neurosklif.ru+7 (916) 423-54-08
PRINCIPAL_INVESTIGATORAlexander Dmitriev, MD

Sklifosovsky Institute of Emergency Care

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 16, 2026